Argan Deferred Long Term Liab vs Cash And Equivalents Analysis

AGX Stock

USD 66.32 1.30 1.92%

Argan financial indicator trend analysis is way more than just evaluating Argan Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Argan Inc is a good investment. Please check the relationship between Argan Deferred Long Term Liab and its Cash And Equivalents accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Argan Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

Deferred Long Term Liab vs Cash And Equivalents

Deferred Long Term Liab vs Cash And Equivalents Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Argan Inc Deferred Long Term Liab account and Cash And Equivalents. At this time, the significance of the direction appears to have weak relationship.

The correlation between Argan's Deferred Long Term Liab and Cash And Equivalents is 0.32. Overlapping area represents the amount of variation of Deferred Long Term Liab that can explain the historical movement of Cash And Equivalents in the same time period over historical financial statements of Argan Inc, assuming nothing else is changed. The correlation between historical values of Argan's Deferred Long Term Liab and Cash And Equivalents is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Deferred Long Term Liab of Argan Inc are associated (or correlated) with its Cash And Equivalents. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Equivalents has no effect on the direction of Deferred Long Term Liab i.e., Argan's Deferred Long Term Liab and Cash And Equivalents go up and down completely randomly.

Correlation Coefficient

0.32

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Cash And Equivalents

Most indicators from Argan's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Argan Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Argan Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

At this time, Argan's Selling General Administrative is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to rise to 10.83 in 2024, despite the fact that Discontinued Operations is likely to grow to (243.7 K).

	2021	2022	2023	2024 (projected)
Total Operating Expenses	47.3M	44.7M	42.4M	44.5M
Cost Of Revenue	409.6M	368.7M	494.5M	519.2M

Total Operating Expenses Cost Of Revenue

Argan fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Other Current Assets	Accounts Payable	Common Stock Total Equity	Common Stock	Current Deferred Revenue
Total Assets		0.28	0.57	0.87	0.89	0.79	-0.41	0.87	0.34	0.88	0.25	0.89	0.67	0.54	0.36	0.25	0.52	0.87	0.75	1.0	0.27	0.66	0.66	0.67	0.68	0.69
Short Long Term Debt Total	0.28		0.46	0.31	0.14	0.15	-0.11	0.28	0.1	0.32	0.23	0.04	0.53	-0.08	0.37	0.32	-0.22	0.36	0.53	0.27	0.55	0.29	-0.15	0.19	0.19	0.31
Other Current Liab	0.57	0.46		0.55	0.41	0.44	-0.13	0.52	0.04	0.64	0.58	0.31	0.68	0.14	0.37	0.61	-0.01	0.59	0.69	0.55	0.45	0.61	0.16	0.35	0.36	0.46
Total Current Liabilities	0.87	0.31	0.55		0.56	0.48	-0.44	0.56	0.36	0.67	0.23	0.81	0.58	0.39	0.07	0.3	0.3	1.0	0.61	0.88	0.24	0.4	0.61	0.53	0.54	0.94
Total Stockholder Equity	0.89	0.14	0.41	0.56		0.88	-0.33	0.94	0.29	0.85	0.15	0.8	0.55	0.6	0.49	0.09	0.66	0.55	0.65	0.88	0.19	0.71	0.59	0.67	0.68	0.32
Property Plant And Equipment Net	0.79	0.15	0.44	0.48	0.88		-0.26	0.86	0.21	0.87	0.25	0.62	0.59	0.43	0.45	0.23	0.51	0.49	0.78	0.77	0.48	0.79	0.36	0.54	0.55	0.27
Net Debt	-0.41	-0.11	-0.13	-0.44	-0.33	-0.26		-0.16	-0.98	-0.14	0.14	-0.57	0.07	-0.59	0.07	0.16	-0.54	-0.42	-0.13	-0.44	-0.08	-0.32	-0.06	-0.55	-0.55	-0.56
Retained Earnings	0.87	0.28	0.52	0.56	0.94	0.86	-0.16		0.1	0.87	0.43	0.66	0.73	0.34	0.63	0.37	0.36	0.58	0.79	0.85	0.4	0.81	0.47	0.51	0.52	0.3
Cash	0.34	0.1	0.04	0.36	0.29	0.21	-0.98	0.1		0.06	-0.22	0.55	-0.2	0.64	-0.15	-0.26	0.58	0.32	0.01	0.37	0.04	0.26	0.09	0.59	0.59	0.47
Non Current Assets Total	0.88	0.32	0.64	0.67	0.85	0.87	-0.14	0.87	0.06		0.35	0.62	0.83	0.41	0.54	0.43	0.38	0.7	0.88	0.85	0.34	0.67	0.45	0.59	0.6	0.46
Non Currrent Assets Other	0.25	0.23	0.58	0.23	0.15	0.25	0.14	0.43	-0.22	0.35		-0.05	0.57	-0.2	0.32	0.94	-0.49	0.29	0.52	0.23	0.56	0.6	-0.08	0.07	0.07	0.13
Cash And Short Term Investments	0.89	0.04	0.31	0.81	0.8	0.62	-0.57	0.66	0.55	0.62	-0.05		0.27	0.69	0.04	-0.1	0.73	0.77	0.39	0.91	0.03	0.46	0.78	0.69	0.7	0.68
Net Receivables	0.67	0.53	0.68	0.58	0.55	0.59	0.07	0.73	-0.2	0.83	0.57	0.27		-0.01	0.68	0.67	-0.11	0.63	0.93	0.64	0.45	0.54	0.16	0.27	0.28	0.42
Common Stock Shares Outstanding	0.54	-0.08	0.14	0.39	0.6	0.43	-0.59	0.34	0.64	0.41	-0.2	0.69	-0.01		-0.03	-0.24	0.87	0.34	0.08	0.54	-0.3	0.22	0.57	0.94	0.93	0.32
Non Current Liabilities Total	0.36	0.37	0.37	0.07	0.49	0.45	0.07	0.63	-0.15	0.54	0.32	0.04	0.68	-0.03		0.37	-0.03	0.12	0.64	0.33	0.22	0.47	-0.09	0.14	0.15	-0.08
Inventory	0.25	0.32	0.61	0.3	0.09	0.23	0.16	0.37	-0.26	0.43	0.94	-0.1	0.67	-0.24	0.37		-0.54	0.36	0.59	0.22	0.54	0.51	-0.15	0.05	0.05	0.22
Other Stockholder Equity	0.52	-0.22	-0.01	0.3	0.66	0.51	-0.54	0.36	0.58	0.38	-0.49	0.73	-0.11	0.87	-0.03	-0.54		0.24	0.04	0.53	-0.33	0.18	0.58	0.71	0.71	0.2
Total Liab	0.87	0.36	0.59	1.0	0.55	0.49	-0.42	0.58	0.32	0.7	0.29	0.77	0.63	0.34	0.12	0.36	0.24		0.67	0.88	0.29	0.43	0.56	0.5	0.51	0.94
Property Plant And Equipment Gross	0.75	0.53	0.69	0.61	0.65	0.78	-0.13	0.79	0.01	0.88	0.52	0.39	0.93	0.08	0.64	0.59	0.04	0.67		0.72	0.63	0.72	0.13	0.35	0.36	0.47
Total Current Assets	1.0	0.27	0.55	0.88	0.88	0.77	-0.44	0.85	0.37	0.85	0.23	0.91	0.64	0.54	0.33	0.22	0.53	0.88	0.72		0.26	0.64	0.67	0.67	0.68	0.71
Short Term Debt	0.27	0.55	0.45	0.24	0.19	0.48	-0.08	0.4	0.04	0.34	0.56	0.03	0.45	-0.3	0.22	0.54	-0.33	0.29	0.63	0.26		0.69	-0.25	-0.05	-0.05	0.19
Other Current Assets	0.66	0.29	0.61	0.4	0.71	0.79	-0.32	0.81	0.26	0.67	0.6	0.46	0.54	0.22	0.47	0.51	0.18	0.43	0.72	0.64	0.69		0.13	0.4	0.4	0.21
Accounts Payable	0.66	-0.15	0.16	0.61	0.59	0.36	-0.06	0.47	0.09	0.45	-0.08	0.78	0.16	0.57	-0.09	-0.15	0.58	0.56	0.13	0.67	-0.25	0.13		0.53	0.53	0.41
Common Stock Total Equity	0.67	0.19	0.35	0.53	0.67	0.54	-0.55	0.51	0.59	0.59	0.07	0.69	0.27	0.94	0.14	0.05	0.71	0.5	0.35	0.67	-0.05	0.4	0.53		1.0	0.43
Common Stock	0.68	0.19	0.36	0.54	0.68	0.55	-0.55	0.52	0.59	0.6	0.07	0.7	0.28	0.93	0.15	0.05	0.71	0.51	0.36	0.68	-0.05	0.4	0.53	1.0		0.44
Current Deferred Revenue	0.69	0.31	0.46	0.94	0.32	0.27	-0.56	0.3	0.47	0.46	0.13	0.68	0.42	0.32	-0.08	0.22	0.2	0.94	0.47	0.71	0.19	0.21	0.41	0.43	0.44

Click cells to compare fundamentals

Argan Account Relationship Matchups

Argan fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	487.5M	602.6M	553.6M	489.5M	623.6M	654.8M
Other Current Liab	34.3M	48.6M	51.9M	48.3M	79.0M	82.9M
Total Current Liabilities	144.0M	276.1M	223.0M	202.5M	302.3M	317.4M
Total Stockholder Equity	339.2M	320.7M	326.4M	280.9M	290.9M	305.5M
Property Plant And Equipment Net	24.9M	24.1M	14.5M	16.5M	18.5M	19.5M
Net Debt	(165.2M)	(364.6M)	(346.8M)	(172.4M)	(191.7M)	(182.1M)
Retained Earnings	189.3M	166.1M	188.7M	207.8M	225.5M	236.8M
Cash	167.4M	366.7M	350.5M	173.9M	197.0M	101.4M
Non Current Assets Total	65.8M	56.4M	46.3M	50.8M	76.4M	80.2M
Non Currrent Assets Other	408K	249K	457K	3.7M	2.3M	2.4M
Cash And Short Term Investments	327.9M	456.7M	440.5M	325.5M	306.5M	321.8M
Net Receivables	70.6M	55.3M	31.9M	74.9M	201.4M	211.5M
Common Stock Shares Outstanding	15.6M	15.8M	15.9M	14.2M	13.5M	8.1M
Liabilities And Stockholders Equity	487.5M	602.6M	553.6M	489.5M	623.6M	654.8M
Non Current Liabilities Total	2.5M	4.1M	5.0M	6.1M	30.4M	31.9M
Other Stockholder Equity	148.7M	153.3M	137.8M	73.6M	66.7M	62.3M
Total Liab	146.5M	280.2M	228.0M	208.6M	332.6M	349.3M
Property Plant And Equipment Gross	22.5M	24.1M	14.5M	16.5M	40.1M	42.1M
Total Current Assets	421.8M	546.2M	507.3M	438.7M	547.2M	574.5M
Short Term Debt	1.6M	2.1M	1.4M	1.6M	2.7M	1.6M
Other Current Assets	23.3M	34.1M	34.9M	38.3M	29.3M	30.7M
Accumulated Other Comprehensive Income	(1.1M)	(1.1M)	(2.5M)	(2.9M)	(3.6M)	(3.4M)
Accounts Payable	35.4M	53.3M	41.8M	56.4M	39.5M	29.8M
Common Stock Total Equity	2.3M	2.4M	2.4M	2.4M	2.7M	1.6M
Common Stock	2.3M	2.4M	2.4M	2.4M	2.7M	1.7M
Current Deferred Revenue	72.7M	172.0M	127.9M	96.3M	181.1M	190.1M
Other Assets	7.9M	249K	457K	3.7M	4.2M	4.5M
Property Plant Equipment	22.5M	20.4M	10.5M	10.4M	12.0M	7.7M
Good Will	34.3M	32.8M	27.9M	28.0M	32.2M	24.6M
Short Term Investments	160.5M	90.1M	90.0M	151.5M	109.5M	81.3M
Intangible Assets	5.0M	4.1M	3.3M	2.6M	2.2M	4.0M
Other Liab	1.8M	4.1M	2.7M	2.9M	3.3M	3.5M
Net Tangible Assets	306.3M	288.6M	295.0M	250.3M	287.8M	248.8M
Noncontrolling Interest In Consolidated Entity	(196K)	1.8M	1.7M	(797K)	(916.6K)	(870.7K)
Retained Earnings Total Equity	189.3M	166.1M	188.7M	207.8M	239.0M	148.9M
Capital Surpluse	148.7M	153.3M	158.2M	162.2M	186.5M	142.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
CRM	Salesforce
MSFT	Microsoft

When determining whether Argan Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Argan's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Argan Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Argan Inc Stock:

How To Invest In Argan

Details

Is Argan Stock a good investment?

Details

What is Argan's Net Worth?

Details

Largest Construction & Engineering Companies

View

Largest Engineering & Construction Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Argan Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

Note that the Argan Inc information on this page should be used as a complementary analysis to other Argan's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Complementary Tools for Argan Stock analysis

When running Argan's price analysis, check to measure Argan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Argan is operating at the current time. Most of Argan's value examination focuses on studying past and present price action to predict the probability of Argan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Argan's price. Additionally, you may evaluate how the addition of Argan to your portfolios can decrease your overall portfolio volatility.

	Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments
	Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Volatility Analysis Get historical volatility and risk analysis based on latest market data
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	Content Syndication Quickly integrate customizable finance content to your own investment portal

Is Argan's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Argan. If investors know Argan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Argan listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.10)

Dividend Share

1.1

Earnings Share

2.39

Revenue Per Share

42.898

Quarterly Revenue Growth

0.385

The market value of Argan Inc is measured differently than its book value, which is the value of Argan that is recorded on the company's balance sheet. Investors also form their own opinion of Argan's value that differs from its market value or its book value, called intrinsic value, which is Argan's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Argan's market value can be influenced by many factors that don't directly affect Argan's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Argan's value and its price as these two are different measures arrived at by different means. Investors typically determine if Argan is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Argan's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Argan Deferred Long Term Liab vs Cash And Equivalents Analysis

Deferred Long Term Liab vs Cash And Equivalents

Deferred Long Term Liab vs Cash And Equivalents Correlation Analysis

Correlation Coefficient

Deferred Long Term Liab

Cash And Equivalents

Argan fundamental ratios Correlations

Argan Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Argan fundamental ratios Accounts

Also Currently Popular

Complementary Tools for Argan Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Common Stock	+ 1.0	Common Stock Total Equity
Current Deferred Revenue	+ 0.94	Total Current Liabilities
Retained Earnings	+ 0.94	Total Stockholder Equity
Inventory	+ 0.94	Non Currrent Assets Other

Cash	- 0.98	Net Debt
Common Stock Shares Outstanding	- 0.59	Net Debt
Cash And Short Term Investments	- 0.57	Net Debt
Current Deferred Revenue	- 0.56	Net Debt
Common Stock	- 0.55	Net Debt
Common Stock Total Equity	- 0.55	Net Debt